secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anixa Biosciences Inc (ANIX)
CIK:        0000715446
Form:       8-K
Filed at:   2025-03-21T23:59:59+00:00
Accession:  0001493152-25-011151
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anixa Biosciences annual meeting re-elects four directors, approves say-on-pay 66%-33%
--------------------------------------------------------------------------------

- Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, Lewis Titterton re-elected as directors with 97-99% of votes cast.
- Executive compensation approved on advisory basis: 6.6M for, 3.4M against (66% support).
- Ratification of Haskell & White LLP as auditor for FY2025 passed with 19.9M for, 187k against.
- Advisory vote on frequency of future say-on-pay: one-year option received 8.7M votes vs 1.1M for three years.
- Broker non-votes totalled 10.5M shares on director elections and compensation proposals (32.7% of outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/715446/000149315225011151/0001493152-25-011151-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/715446/000149315225011151/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-011151

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer